KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested Capital

AbCellera Biologics (ABCL) Asset Utilization Ratio (2021 - 2024)

AbCellera Biologics' Asset Utilization Ratio history spans 4 years, with the latest figure at 0.01 for Q3 2024.

  • For the quarter ending Q3 2024, Asset Utilization Ratio fell 80.2% year-over-year to 0.01, compared with a TTM value of 0.01 through Sep 2024, down 80.2%, and an annual FY2024 reading of 0.02, down 19.37% over the prior year.
  • Asset Utilization Ratio for Q3 2024 was 0.01 at AbCellera Biologics, down from 0.01 in the prior quarter.
  • The five-year high for Asset Utilization Ratio was 0.4 in Q1 2021, with the low at 0.01 in Q3 2024.
  • Average Asset Utilization Ratio over 4 years is 0.21, with a median of 0.3 recorded in 2021.
  • Year-over-year, Asset Utilization Ratio increased 4.19% in 2022 and then crashed 91.92% in 2023.
  • Tracing ABCL's Asset Utilization Ratio over 4 years: stood at 0.3 in 2021, then grew by 4.19% to 0.31 in 2022, then crashed by 91.92% to 0.03 in 2023, then plummeted by 74.18% to 0.01 in 2024.
  • Per Business Quant, the three most recent readings for ABCL's Asset Utilization Ratio are 0.01 (Q3 2024), 0.01 (Q2 2024), and 0.02 (Q1 2024).